Q4 2023 Holdings
Filed 2024-02-14 | 7 holdings | $163.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revolution Medicines, Inc.(RVMD) | COM | 76155X100 | $92.7M | 3,233,490 | 56.7% |
| Verve Therapeutics, Inc. | COM | 92539P101 | $28.0M | 2,008,809 | 17.1% |
| Erasca, Inc.(ERAS) | COM | 29479A108 | $23.5M | 11,055,554 | 14.4% |
| Denali Therapeutics, Inc.(DNLI) | COM | 24823R105 | $8.2M | 381,249 | 5.0% |
| Gossamer BIO, Inc.(GOSS) | COM | 38341P102 | $7.4M | 8,055,916 | 4.5% |
| Unity Biotechnology, Inc.(UNBX) | COM | 91381U200 | $1.9M | 1,004,817 | 1.2% |
| Singular Genomics Systems, Inc. | COM | 82933R100 | $1.7M | 3,798,926 | 1.1% |